Page last updated: 2024-10-19

phytic acid and Alloxan Diabetes

phytic acid has been researched along with Alloxan Diabetes in 6 studies

Phytic Acid: Complexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent.
myo-inositol hexakisphosphate : A myo-inositol hexakisphosphate in which each hydroxy group of myo-inositol is monophosphorylated.

Research Excerpts

ExcerptRelevanceReference
" Body weight, blood glucose, glycated haemoglobin, insulin, serum leptin, HOMA-insulin resistance scores, intestinal amylase activity, serum and faecal lipids and food and fluid consumption were measured."3.83The effect of combined inositol hexakisphosphate and inositol supplement in streptozotocin-induced type 2 diabetic rats. ( Bustamante, J; Dilworth, LL; Foster, SR; Lindo, RL; Omoruyi, FO, 2016)
" The microspheres had a relative pharmacological bioavailability of 10."1.56Optimization of phytic acid-crosslinked chitosan microspheres for oral insulin delivery using response surface methodology. ( Kim, JU; Kim, T; Lee, H; Park, J; Roh, YH; Shahbaz, HM; Yang, K, 2020)
"Type 2 diabetes was induced in three groups using high-fat diet combined with a single dose of streptozotocin (35mg/kg body weight, intraperitoneally)."1.46Pancreatic and renal function in streptozotocin-induced type 2 diabetic rats administered combined inositol hexakisphosphate and inositol supplement. ( Alexander-Lindo, RL; Dilworth, LL; Foster, SR; Omoruyi, FO; Thompson, R, 2017)
"Phytic acid (PA) was used as a cross-linking agent for encapsulation of insulin in a chitosan matrix for oral delivery of insulin."1.37Oral delivery of insulin using chitosan capsules cross-linked with phytic acid. ( Cho, S; Ghafoor, K; Jeong, C; Lee, H; Park, J, 2011)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Kim, JU1
Shahbaz, HM1
Lee, H2
Kim, T1
Yang, K1
Roh, YH1
Park, J2
Foster, SR3
Dilworth, LL3
Thompson, RK1
Alexander-Lindo, RL2
Omoruyi, FO3
Thompson, R1
Bustamante, J1
Lindo, RL1
Jeong, C1
Ghafoor, K1
Cho, S1
Kuppusamy, A1
Muthusamy, U1
Thirumalaisamy, SA1
Varadharajan, S1
Ramasamy, K1
Ramanathan, S1

Other Studies

6 other studies available for phytic acid and Alloxan Diabetes

ArticleYear
Optimization of phytic acid-crosslinked chitosan microspheres for oral insulin delivery using response surface methodology.
    International journal of pharmaceutics, 2020, Oct-15, Volume: 588

    Topics: Administration, Oral; Animals; Caco-2 Cells; Chitosan; Diabetes Mellitus, Experimental; Drug Carrier

2020
Effects of combined inositol hexakisphosphate and inositol supplement on antioxidant activity and metabolic enzymes in the liver of streptozotocin-induced type 2 diabetic rats.
    Chemico-biological interactions, 2017, Sep-25, Volume: 275

    Topics: Animals; Antioxidants; Bilirubin; Diabetes Mellitus, Experimental; Dietary Supplements; Enzyme Activ

2017
Pancreatic and renal function in streptozotocin-induced type 2 diabetic rats administered combined inositol hexakisphosphate and inositol supplement.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 96

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Supplements; Drug Thera

2017
The effect of combined inositol hexakisphosphate and inositol supplement in streptozotocin-induced type 2 diabetic rats.
    International journal of experimental pathology, 2016, Volume: 97, Issue:5

    Topics: Amylases; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, T

2016
Oral delivery of insulin using chitosan capsules cross-linked with phytic acid.
    Bio-medical materials and engineering, 2011, Volume: 21, Issue:1

    Topics: Administration, Oral; Animals; Capsules; Chitosan; Cross-Linking Reagents; Diabetes Mellitus, Experi

2011
In vitro (α-glucosidase and α-amylase inhibition) and in vivo antidiabetic property of phytic acid (IP6) in streptozotocin- nicotinamide-induced type 2 diabetes mellitus (NIDDM) in rats.
    Journal of complementary & integrative medicine, 2011, Volume: 8

    Topics: alpha-Amylases; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Free Radical S

2011